12
Participants
Start Date
May 17, 2024
Primary Completion Date
October 1, 2024
Study Completion Date
October 31, 2024
Reprieve Decongestion Management System
The Reprieve Decongestion Management System, or Reprieve DMS, is a hospital bedside fluid management console designed to provide personalized and automated infusion of the IV diuretic furosemide and physiological saline in response to the patient's real-time urine output to safely and rapidly decongest patients suffering from Acute Decompensated Heart Failure.
Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide)
Best practices of optimal diuretic dosing such as those demonstrated in recent randomized trials (DOSE, ADVOR, CLOROTIC).
University Medical Center Groningen, Groningen
Wroclaw Medical University, Wroclaw
Reprieve Cardiovascular, Inc
INDUSTRY